Kytril: profile and news

GlaxoSmithKline: Zofran sales set for off-Par performance Nov 22, 2005
...in 2007. This is especially bad news for GSK, as Zofran is already facing competition from Roche's Kytril (granisetron). Indeed, the ... - Pharmaceutical Business Review

NEWS SNAP: GSK Sees 4 Drugs In Phase 3 In '06 - 2 Nov 30, 2005
2006. Zofran, which had sales of $1.4 billion in 2004, competes against Roche's Kytril and Sanofi-Aventis's (SNY) Anzemet. GlaxoSmithkline ... - Business Online,

GSKâ€™s $150M Pricing Settlement Sep 21, 2005
...a civil settlement of $149 million plus interest payments to resolve allegations that it fraudulently priced and marketed drugs Zofran and Kytril, which are ... - Red Herring,

GlaxoSmithKline Pays $150 Million to Settle Drug Pricing Fraud ... Sep 20, 2005
...that the company violated the False Claims Act through fraudulent drug pricing and marketing of two anti-emetic drugs, Zofran and Kytril, used primarily in ... - PharmaLive.com (press release),

GlaxoSmithKline, Government Reach Civil Settlement Sep 22, 2005
...of Health and Human Services to resolve the federal governmentâ€™s â€œAverage Wholesale Priceâ€? investigation concerning Zofran and Kytril, drugs used to ... - PharmaLive.com (press release),

GlaxoSmithKline Settles Fraud Charges for $150 Million Sep 21, 2005
...that it defrauded Medicare and other federal health programs through fraudulent drug pricing and marketing of two drugs used in cancer care, Zofran and Kytril. ... - Consumer Affairs

GlaxoSmithKline settles fraud suit for $150 million US Sep 20, 2005
...programs. The US Justice Department opened an investigation concerning inflated prices for the anti-nausea drugs Zofran and Kytril. ... - CBC News,

Glaxo settles US drug pricing case Sep 20, 2005
...on Wednesday. The two drugs, Zofran and Kytril, help to quell vomiting associated with cancer and radiation treatment. Their promotion ... - Economic Times,

GlaxoSmithKline to pay $150.8 million to settle Justice Department ... Sep 20, 2005
...government claimed GlaxoSmithKline, with US headquarters in Philadelphia, engaged in a scheme to overharge for two injectible drugs, Zofran and Kytril, used to ... - philly.com,

Glaxo to settle on fraud charges Sep 21, 2005
...claimed GlaxoSmithKline, with a US headquarters in Philadelphia, engaged in a scheme to overcharge for two injectible drugs, Zofran and Kytril, used to prevent ... - philly.com,

Prescription Drugs | GlaxoSmithKline Agrees To Pay $150.8M To ... Sep 21, 2005
The Department of Justice claimed that GSK purposely overcharged government health care programs for Zofran and Kytril, two injectable drugs used to prevent ... - Kaiser network.org,

Glaxo Settles Suit Sep 20, 2005
...to overcharge for two antinausea drugs: Zofran for preventing nausea and vomiting for patients undergoing chemotherapy or surgery, and Kytril for chemotherapy ... - TheStreet.com

Whistle-blowers reap $26 million Sep 22, 2005
...based in London and Philadelphia, issued a statement saying the accusations were based on the pricing of Zofran from 1994 to 2002 and of Kytril from 1994 to ... - Miami Herald,

GlaxoSmithKline pays $150M fine to US Sep 20, 2005
The accusations concern the way anti-nausea drugs Zofran and Kytril, used primarily in conjunction with oncology and radiation treatment, were handled, the ... - Monsters and Critics.com,

Glaxo to pay $150M to settle fraudulent pricing case Sep 20, 2005
The Justice Department said Glaxo (NYSE: GSK) was accused of violating the federal False Claims Act with its pricing of Zofran and Kytril, which are mainly ... - Pittsburgh Business Times,

$150 Million GlaxoSmithKline Settlement Brings Whistleblowers $26 ... Sep 24, 2005
...a firm based in Philadelphia and London, which produces the antidepressant Wellbutrin, was accused of overpricing Zofran (1994-2002) and Kytril (1994-2000 ... - Newsinferno.com,

Drug maker settles suit over prices Sep 21, 2005
...claimed Glaxo-SmithKline, with a US headquarters in Philadelphia, engaged in a scheme to overcharge for two injectable drugs, Zofran and Kytril, used to ... - Whittier Daily News,

GlaxoSmithKline Pays $150M in Settlement Sep 20, 2005
The pharmaceutical maker engaged in a scheme to inflate the price of Zofran and Kytril for the federal Medicare and Medicaid programs, which reimburse health ... - ABC News

Glaxo settles drug pricing case, US says Sep 20, 2005
The settlement stems from allegations that the company violated the US False Claims Act in the sale and marketing of Zofran and Kytril, two nausea drugs ... - Reuters.uk,

GlaxoSmithKline pays to settle allegations Sep 20, 2005
The pharmaceutical maker engaged in a scheme to inflate the price of Zofran and Kytril for the federal Medicare and Medicaid programs, which reimburse health ... - BusinessWeek

GlaxoSmithKline pays $150 million in Medicare fraud case Sep 20, 2005
The pharmaceutical maker inflated the price of Zofran and Kytril for the federal Medicare and Medicaid programs, which reimburse health care providers based on ... - USA Today

Glaxo Settles Drug Pricing Charges for $150M Sep 20, 2005
...stems from allegations that the British company violated the False Claims Act (search) in the sale and marketing of Zofran (search) and Kytril (search), two ... - FOX News

Glaxo Settles US Fraud Charges Sep 20, 2005
Glaxo, according to the government, engaged in an effort to inflate the price of the two drugs, Zofran and Kytril, for the federal Medicare and Medicaid ... - New York Times,

Glaxo agrees to pay $150m in drug-price fraud case Sep 21, 2005
Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs, which reimburse healthcare providers based on the ... - Boston Globe,

Glaxo to pay 150 million dollars to settle drug price fraud claims Sep 21, 2005
The company is accused of violating the US False Claims Act in the sale and marketing of the anti-nausea prescription drugs Zofran and Kytril for cancer ... - People's Daily Online,

Glaxo to settle overcharge claims Sep 21, 2005
The Justice Department said Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs, which reimburse health ... - San Diego Union Tribune,

Glaxo agrees $151m payout to settle US claims it inflated the ... Sep 20, 2005
...matter behind it.". The settlement covers two drugs used to treat nausea associated with chemotherapy, Zofran and Kytril. So far, only ... - Independent,

GlaxoSmithKline pays $150 million to settle fraud allegations Sep 20, 2005
...maker, which has US headquarters in Research Triange Park, NC, and Pennsylvania, engaged in a scheme to inflate the price of Zofran and Kytril for the federal ... - WCNC (subscription),

GlaxoSmithKline pays $150 million to settle drug price probe Sep 20, 2005
The pharmaceutical maker was accused of engaging in a scheme to inflate the price of Zofran and Kytril for the federal Medicare and Medicaid programs, which ... - Eyewitness News,

GlaxoSmithKline Pays $150 Million to Settle Price Fixing Charges Sep 21, 2005
According to the US Department of Justice, Glaxo allegedly violated the federal False Claims Act in the sale and marketing of Zofran and Kytril, two nausea ... - Newsinferno.com,

Glaxo settles overcharge claim Sep 21, 2005
Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs, which reimburse health care providers based on the ... - Fort Wayne Journal Gazette,

GSK to settle in fraud case Sep 22, 2005
...maker, which has US headquarters in Research Triangle Park and Pennsylvania, engaged in a scheme to inflate the price of Zofran and Kytril for the federal ... - News & Observer,

Business briefs Sep 21, 2005
The pharmaceutical maker engaged in a scheme to inflate the price of Zofran and Kytril for Medicare and Medicaid programs, the government said. ... - The News Journal,

Business Roundup Sep 20, 2005
The accusations concern the way anti-nausea drugs Zofran and Kytril, used primarily in conjunction with oncology and radiation treatment, were handled, the ... - Monsters and Critics.com,

Roche to acquire rights to promising portfolio of cancer drugs ... Oct 3, 2005
It also includes NeoRecormon (epoetin beta), Roferon-A (interferon alfa-2a), Neupogen (Filgrastim) and Kytril (granisetron HCl). ... - Biotechnology Investment Today (Press Release),

Roche and Epigenomics sign broad cancer diagnostics alliance Oct 3, 2005
...anaemia in various cancer settings), Roferon-A (leukaemia, Kaposiâ€™s sarcoma, malignant melanoma, renal cell carcinoma) and Kytril (chemotherapy and ... - Biotechnology Investment Today (Press Release),

GlaxoSmithKline pays 150 mln usd to settle US drug pricing case Sep 20, 2005
...care programmes. The two drugs, Zofran and Kytril, help to quell vomiting associated with oncology and radiation treatment. Their ... - Forbes

Nation/world briefs Sep 20, 2005
The government said the pharmaceutical maker engaged in a scheme to inflate the price of Zofran and Kytril for Medicare and Medicaid, which reimburse health ... - Arizona Republic,

GlaxoSmithKline Pays $150 Million In Drug Pricing Fraud Case:DOJ Sep 20, 2005
The government alleges that Glaxo was reimbursed from federal health programs based on inflated prices of its anti-emetic drugs Zofran and Kytril. ... - Business Online,

Glaxo to pay $150 million in settlement Sep 20, 2005
...manufacturer, which has headquarters in Research Triangle Park, NC, and Pennsylvania, engaged in a scheme to inflate the price of Zofran and Kytril for the ... - Winston-Salem Journal,

Tarceva Approved in Europe for Lung Cancer Sep 20, 2005
Bondronat (for prevention of skeletal events in patients with breast cancer and bone metastases, hypercalcaemia of malignancy), Kytril (for chemotherapy and ... - PR Newswire UK (press release),

Business Briefs Sep 20, 2005
The government said Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs. ... - Richmond Times Dispatch,

Daily Briefing Sep 21, 2005
...maker, which has US headquarters in Research Triangle Park, NC, and Pennsylvania, engaged in a scheme to inflate the price of Zofran and Kytril for the federal ... - Atlanta Journal Constitution (subscription),

UPDATE 1-Teva gets tentative FDA nod for nausea drug Aug 17, 2005
...regulators have granted tentative approval for a generic version of Swiss drugmaker Roche's (ROG.VX: Quote, Profile, Research) injectable drug Kytril to treat ... - Reuters

Teva's generic nausea drug gets tentative US approval Aug 18, 2005
The FDA has granted tentative approval to Teva Pharmaceutical's application to market a generic version of Roche AG's injectable drug Kytril, an anti-nausea ... - Pharmaceutical Business Review

Business in Brief Aug 19, 2005
...that the US Food and Drug Administration had granted tentative approval for a generic version of Swiss drugmaker Roche's injectable drug Kytril to treat nausea ... - Ha'aretz (registration),

FDA approves Teva anti-nausea drug Aug 17, 2005
Teva's Granisetron HCl Injection products are the generic equivalents of Hoffman-La Roche's antinauseant and antiemetic agent Kytril Injection. ... - Globes,

Teva Announces Tentative Approval of Granisetron Hydrochloride ... Aug 17, 2005
Teva's Granisetron HCl Injection products are the generic equivalents of Hoffman-La Roche's antinauseant and antiemetic agent Kytril(R) Injection. ... - Business Wire (press release),

Case Charging Nation's Largest Drug Companies of Defrauding ... Aug 18, 2005
...be counted." The prescription drugs mentioned in the complaint include: -- Alkeran -- Blenoxane -- Cytoxan -- Etopophos -- Kytril -- Navelbine -- Paraplatin ... - PR Newswire (press release),

Spector, Roseman & Kodroff, PC Say Federal Judge Allows Consumers ... Aug 19, 2005
The prescription drugs mentioned in this complaint include: Alkeran, Blenoxane, Cytoxan, Etopophos, Kytril, Navelbine, Paraplatin, Procrit, Remicade, Rubex ... - Business Wire (press release),

Marci Piasecki Named CEO of Torre Lazur McCann US Jul 11, 2005
Piaseckiâ€™s vast category/brand/launch experience includes Oncology launch experience with GlaxoSmithKlineâ€™s Hycamtin and Kytril. ... - PharmaLive.com (press release)

COMUNICADO DE ROCHE PHARMACEUTICALS (1) Jul 13, 2005
Bondronat (for prevention of skeletal events in patients with breast cancer and bone metastases, hypercalcaemia of malignancy), Kytril (for chemotherapy and ... - Europa Press

Anti-nausea drugs also under study locally Jul 18, 2005
...and would like to participate in a different study of an anti-nausea drug may be eligible to try the polymer form of the common anti-nausea drug Kytril. ... - Canton Repository (subscription) <**results**>

Avastin may be cancer wonder drug for pancreatic, renal, ovarian ... Apr 16, 2005
...settings), Bondronat (prevention of skeletal events in breast cancer and bone metastases patients, hypercalcaemia of malignancy), Kytril (chemotherapy and ... - Medical News Today,